Company / Cost of Revenue
Bruker Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.9B
FY2025
5-year range
$1.2B / $1.9B
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#30 of 107
Health Care
What the data says
At $1.9B, Bruker's cost of revenue ranks #78 of 107 in the Health Care sector. Cost of Revenue has increased for 5 consecutive years, from $1.0B in FY2020 to $1.9B in FY2025.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +12.1%.
Increased from $1.5B to $1.9B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
#78 of 107 in Health CareTop 72% of 107This company $1.9B Sector average $11.8B
▼
-84.2% below sector average
Key checks
Key Insights
- Bruker's cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +12.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 8.3% year-over-year.
- Ranks #30 out of 107 companies in the Health Care sector.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +8.3% |
| FY2024 | $1.7B | +18.3% |
| FY2023 | $1.5B | +18.5% |
| FY2022 | $1.2B | +1.4% |
| FY2021 | $1.2B | +15.3% |
| FY2020 | $1.0B | -2.7% |
| FY2019 | $1.1B | +8.2% |
| FY2018 | $995.6M | +4.8% |
| FY2017 | $949.9M | +9.7% |
| FY2016 | $866.0M | -5.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026